GlassScriptPhysician profile
Erik T Interval
NPI 1447517156
$3,018.85
in general payments reported to CMS, 2019-2025
21 companies · $742 in 2025
The $742 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $846 · 2023: $504 · 2024: $926 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,063.72 |
| Education | $108.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $478.49 | 2022-2025 | |
| Csl Behring | $451.94 | 2022-2025 | Haegarda, Andembry |
| Regeneron Healthcare Solutions, INC. | $354.38 | 2022-2025 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $331.52 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $288.61 | 2022-2025 | Nucala |
| Optinose US, INC. | $274.12 | 2022-2025 | |
| Inspire Medical Systems, INC. | $221.73 | 2022-2025 | Inspire |
| Abbvie INC. | $114.53 | 2023-2024 | |
| Kaleo, INC. | $114.04 | 2022-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $98.99 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $68.47 | 2022-2025 | Caldolor |
| Stryker Corporation | $56.64 | 2022 | |
| Smith+Nephew, INC. | $22.85 | 2025 | Tula |
| Aerin Medical INC. | $21.20 | 2022 | |
| Merck Sharp & Dohme LLC | $20.43 | 2025 | Keytruda |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $19.56 | 2023 | Immunocap |
| Pfizer INC. | $17.51 | 2023 | |
| Tactile Systems Technology INC | $16.76 | 2024 | Flexitouch Plus, Entre Plus |
| Organogenesis INC. | $16.50 | 2024 | |
| Becton, Dickinson and Company | $15.69 | 2024 | Arista Ah Flexitip |
| Biohaven Pharmaceutical Holding Company LTD. | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Interval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.